AI companies calling for a coordinated development 'slowdown' to address safety risks face antitrust concerns, as regulators may interpret their language as collusive output reduction rather than legitimate safety measures. Antitrust experts argue that emphasizing safety protocols and alignment rather than explicit 'slowdown' language would better withstand legal scrutiny under existing antitrust doctrine.